Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Increased Risk of Pseudoprogression among Pediatric Low-Grade Glioma Patients Treated with Proton versus Photon Radiotherapy.

Ludmir EB, Mahajan A, Paulino AC, Jones JY, Ketonen LM, Su JM, Grosshans DR, McAleer MF, McGovern SL, Lassen-Ramshad YA, Adesina AM, Dauser RC, Weinberg JS, Chintagumpala MM.

Neuro Oncol. 2019 Feb 7. doi: 10.1093/neuonc/noz042. [Epub ahead of print]

PMID:
30753704
2.

Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide.

Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA.

J Neurooncol. 2019 Mar;142(1):69-77. doi: 10.1007/s11060-018-03063-1. Epub 2018 Nov 28.

PMID:
30488294
3.

Incidence of pseudoprogression in low-grade gliomas treated with radiotherapy.

van West SE, de Bruin HG, van de Langerijt B, Swaak-Kragten AT, van den Bent MJ, Taal W.

Neuro Oncol. 2017 May 1;19(5):719-725. doi: 10.1093/neuonc/now194.

4.

Sequential proton boost after standard chemoradiation for high-grade glioma.

Adeberg S, Bernhardt D, Harrabi SB, Uhl M, Paul A, Bougatf N, Verma V, Unterberg A, Wick W, Haberer T, Combs SE, Herfarth K, Debus J, Rieken S.

Radiother Oncol. 2017 Nov;125(2):266-272. doi: 10.1016/j.radonc.2017.09.040. Epub 2017 Oct 16.

PMID:
29050959
5.

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma.

Bronk JK, Guha-Thakurta N, Allen PK, Mahajan A, Grosshans DR, McGovern SL.

Clin Transl Radiat Oncol. 2018 Jan 12;9:30-34. doi: 10.1016/j.ctro.2018.01.002. eCollection 2018 Feb.

6.

A comparison of critical structure dose and toxicity risks in patients with low grade gliomas treated with IMRT versus proton radiation therapy.

Dennis ER, Bussiere MR, Niemierko A, Lu MW, Fullerton BC, Loeffler JS, Shih HA.

Technol Cancer Res Treat. 2013 Feb;12(1):1-9. doi: 10.7785/tcrt.2012.500276. Epub 2012 Jul 10.

PMID:
22775339
7.

Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.

Shiraishi Y, Xu C, Yang J, Komaki R, Lin SH.

Radiother Oncol. 2017 Oct;125(1):48-54. doi: 10.1016/j.radonc.2017.07.034. Epub 2017 Sep 13.

PMID:
28917586
8.

A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.

Fang P, Mick R, Deville C, Both S, Bekelman JE, Christodouleas JP, Guzzo TJ, Tochner Z, Hahn SM, Vapiwala N.

Cancer. 2015 Apr 1;121(7):1118-27. doi: 10.1002/cncr.29148. Epub 2014 Nov 25.

9.

Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.

Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, Mackay A, Jones DT, Hovestadt V, Marshall LV, Vaidya S, Mandeville H, Jerome N, Bridges LR, Laxton R, Al-Sarraj S, Pfister SM, Leach MO, Pearson AD, Jones C, Koh DM, Zacharoulis S.

J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.

PMID:
27180091
10.

Patterns of failure following proton beam therapy for head and neck rhabdomyosarcoma.

Ludmir EB, Grosshans DR, McAleer MF, McGovern SL, Harrison DJ, Okcu MF, Chintagumpala MM, Mahajan A, Paulino AC.

Radiother Oncol. 2019 May;134:143-150. doi: 10.1016/j.radonc.2019.02.002. Epub 2019 Feb 14.

PMID:
31005208
11.

A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors.

Takizawa D, Mizumoto M, Yamamoto T, Oshiro Y, Fukushima H, Fukushima T, Terunuma T, Okumura T, Tsuboi K, Sakurai H.

Radiat Oncol. 2017 Feb 22;12(1):40. doi: 10.1186/s13014-017-0775-2.

12.

Radiotherapy Treatments for Head and Neck Cancer Update [Internet].

Ratko TA, Douglas GW, de Souza JA, Belinson SE, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec.

13.

Pseudoprogression in pediatric low-grade glioma after irradiation.

Tsang DS, Murphy ES, Lucas JT Jr, Lagiou P, Acharya S, Merchant TE.

J Neurooncol. 2017 Nov;135(2):371-379. doi: 10.1007/s11060-017-2583-9. Epub 2017 Jul 27.

PMID:
28752498
14.

First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.

Remick JS, Schonewolf C, Gabriel P, Doucette A, Levin WP, Kucharczuk JC, Singhal S, Pechet TTV, Rengan R, Simone CB 2nd, Berman AT.

Clin Lung Cancer. 2017 Jul;18(4):364-371. doi: 10.1016/j.cllc.2016.12.009. Epub 2017 Jan 5.

PMID:
28162946
15.

Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.

Hirano Y, Onozawa M, Hojo H, Motegi A, Zenda S, Hotta K, Moriya S, Tachibana H, Nakamura N, Kojima T, Akimoto T.

Radiat Oncol. 2018 Feb 9;13(1):23. doi: 10.1186/s13014-018-0966-5.

16.

Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.

Rwigema JM, Verma V, Lin L, Berman AT, Levin WP, Evans TL, Aggarwal C, Rengan R, Langer C, Cohen RB, Simone CB 2nd.

Cancer. 2017 Nov 1;123(21):4244-4251. doi: 10.1002/cncr.30870. Epub 2017 Jul 5.

17.

Pseudoprogression of low-grade gliomas after radiotherapy.

Naftel RP, Pollack IF, Zuccoli G, Deutsch M, Jakacki RI.

Pediatr Blood Cancer. 2015 Jan;62(1):35-9. doi: 10.1002/pbc.25179. Epub 2014 Sep 11.

PMID:
25213668
18.

Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.

Ojerholm E, Kirk ML, Thompson RF, Zhai H, Metz JM, Both S, Ben-Josef E, Plastaras JP.

Acta Oncol. 2015;54(8):1209-17. doi: 10.3109/0284186X.2014.1002570. Epub 2015 Mar 3.

PMID:
25734796
19.

Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.

Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y, Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker IR, McDonald MW, Curran WJ, Patel KR.

Front Oncol. 2018 Nov 28;8:440. doi: 10.3389/fonc.2018.00440. eCollection 2018.

20.

Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.

Paulino AC, Mazloom A, Terashima K, Su J, Adesina AM, Okcu MF, Teh BS, Chintagumpala M.

Cancer. 2013 Jul 15;119(14):2654-9. doi: 10.1002/cncr.28118. Epub 2013 Apr 30.

Supplemental Content

Support Center